What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?

Viruses

Volumn 3, Issue 2, 2011, Pages 118-131

  Boname, Jessica M ^a   Lehner, Paul J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

E2 conjugating enzyme; Endocytosis; K3; K5; Lysine11; Lysine63; Membrane associated RING CH (MARCH); Ubiquitin; Viral E3 ligase

Indexed keywords

CYSTEINE; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION LIGASE E3; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; K3 UBIQUITIN PROTEIN LIGASE E3; K5 UBIQUITIN PROTEIN LIGASE E3; LEUKEMIA ASSOCIATED PROTEIN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ASSOCIATED RING CH FAMILY LIGASE E3; PLANT HOMEODOMAIN PROTEIN; POLYUBIQUITIN; RING CH DOMAIN PROTEIN; RING FINGER PROTEIN; UBIQUITIN; UBIQUITIN BINDING DOMAIN PROTEIN; UBIQUITIN CONJUGATING ENZYME 13; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CELL SURFACE; DOWN REGULATION; ENDOCYTOSIS; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HLA SYSTEM; HUMAN HERPESVIRUS 8; INTERNALIZATION; LINKAGE ANALYSIS; LYSOSOME; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN DOMAIN; RECEPTOR DOWN REGULATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; UBIQUITINATION; VIRUS ENTRY;

ENDOCYTOSIS; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; LYSINE; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN BINDING; SARCOMA, KAPOSI; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

HUMAN HERPESVIRUS 8;

EID: 79952150578     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3020118     Document Type: Article

References (70)

1. Hershko, A.; Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 1998, 67, 425-479.
2. Ferber, S.; Ciechanover, A. Transfer RNA is required for conjugation of ubiquitin to selective substrates of the ubiquitin- and ATP-dependent proteolytic system. J. Biol. Chem. 1986, 261, 3128-3134.
3. Wertz, I.E.; Dixit, V.M. Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ. 2010, 17, 14-24.
4. Markson, G.; Kiel, C.; Hyde, R.; Brown, S.; Charalabous, P.; Bremm, A.; Semple, J.; Woodsmith, J.; Duley, S.; Salehi-Ashtiani, K.; Vidal, M.; Komander, D.; Serrano, L.; Lehner, P.; Sanderson, C.M. Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network. Genome Res. 2009, 19, 1905-1911.
5. Deshaies, R.J.; Joazeiro, C.A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 2009, 78, 399-434.
6. Bremm, A.; Freund, S.M.; Komander, D. Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 2010, 17, 939-947.
7. Randow, F.; Lehner, P.J. Viral avoidance and exploitation of the ubiquitin system. Nat. Cell Biol. 2009, 11, 527-534.
8. Stevenson, P.G.; Efstathiou, S.; Doherty, P.C.; Lehner, P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 8455-8460.
9. Coscoy, L.; Ganem, D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 8051-8056.
10. Ishido, S.; Choi, J.K.; Lee, B.S.; Wang, C.; DeMaria, M.; Johnson, R.P.; Cohen, G.B.; Jung, J.U. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 2000, 13, 365-374.
11. Haque, M.; Ueda, K.; Nakano, K.; Hirata, Y.; Parravicini, C.; Corbellino, M.; Yamanishi, K. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J. Gen. Virol. 2001, 82, 1175-1180.
12. Coscoy, L.; Ganem, D. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 2001, 107, 1599-1606.
13. Boname, J.M.; Stevenson, P.G. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 2001, 15, 627-636.
14. Nicholas, J.; Ruvolo, V.; Zong, J.; Ciufo, D.; Guo, H.G.; Reitz, M.S.; Hayward, G.S. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 1997, 71, 1963-1974.
15. Dodd, R.B.; Allen, M.D.; Brown, S.E.; Sanderson, C.M.; Duncan, L.M.; Lehner, P.J.; Bycroft, M.; Read, R.J. Solution structure of the Kaposi's sarcoma-associated herpesvirus K3 N-terminal domain reveals a Novel E2-binding C4HC3-type RING domain. J. Biol. Chem. 2004, 279, 53840-53847.
16. Bartee, E.; Mansouri, M.; Hovey Nerenberg, B.T.; Gouveia, K.; Fruh, K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 2004, 78, 1109-1120.
17. Lehner, P.J.; Hoer, S.; Dodd, R.; Duncan, L.M. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 2005, 207, 112-125.
18. Hewitt, E.W.; Duncan, L.; Mufti, D.; Baker, J.; Stevenson, P.G.; Lehner, P.J. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J. 2002, 21, 2418-2429.
19. Coscoy, L.; Sanchez, D.J.; Ganem, D. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 2001, 155, 1265-1273.
20. Wang, X.; Ye, Y.; Lencer, W.; Hansen, T.H. The viral E3 ubiquitin ligase mK3 uses the Derlin/p97 endoplasmic reticulum-associated degradation pathway to mediate down-regulation of major histocompatibility complex class I proteins. J. Biol. Chem. 2006, 281, 8636-8644.
21. Yu, Y.Y.; Harris, M.R.; Lybarger, L.; Kimpler, L.A.; Myers, N.B.; Virgin, H.W.t.; Hansen, T.H. Physical association of the K3 protein of gamma-2 herpesvirus 68 with major histocompatibility complex class I molecules with impaired peptide and beta(2)-microglobulin assembly. J. Virol. 2002, 76, 2796-2803.
22. Boname, J.M.; de Lima, B.D.; Lehner, P.J.; Stevenson, P.G. Viral degradation of the MHC class I peptide loading complex. Immunity 2004, 20, 305-317.
23. Boname, J.M.; May, J.S.; Stevenson, P.G. The murine gamma-herpesvirus-68 MK3 protein causes TAP degradation independent of MHC class I heavy chain degradation. Eur. J. Immunol. 2005, 35, 171-179.
24. Mansouri, M.; Douglas, J.; Rose, P.P.; Gouveia, K.; Thomas, G.; Means, R.E.; Moses, A.V.; Fruh, K. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 2006, 108, 1932-1940.
25. Sanchez, D.J.; Gumperz, J.E.; Ganem, D. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 2005, 115, 1369-1378.
26. Manes, T.D.; Hoer, S.; Muller, W.A.; Lehner, P.J.; Pober, J.S. Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins. J. Immunol. 2010, 184, 5186-5192.
27. Li, Q.; Means, R.; Lang, S.; Jung, J.U. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J. Virol. 2007, 81, 2117-2127.
28. Rhodes, D.A.; Boyle, L.H.; Boname, J.M.; Lehner, P.J.; Trowsdale, J. Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 16240-16245.
29. Mansouri, M.; Rose, P.P.; Moses, A.V.; Fruh, K. Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus. J. Virol. 2008, 82, 9615-9628.
30. Thomas, M.; Boname, J.M.; Field, S.; Nejentsev, S.; Salio, M.; Cerundolo, V.; Wills, M.; Lehner, P.J. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 1656-1661.
31. Bartee, E.; McCormack, A.; Fruh, K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2006, 2, e107.
32. Mansouri, M.; Viswanathan, K.; Douglas, J.L.; Hines, J.; Gustin, J.; Moses, A.V.; Fruh, K. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2009, 83, 9672-9681.
33. Pardieu, C.; Vigan, R.; Wilson, S.J.; Calvi, A.; Zang, T.; Bieniasz, P.; Kellam, P.; Towers, G.J.; Neil, S.J. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog. 2010, 6, e1000843.
34. Durrington, H.J.; Upton, P.D.; Hoer, S.; Boname, J.; Dunmore, B.J.; Yang, J.; Crilley, T.K.; Butler, L.M.; Blackbourn, D.J.; Nash, G.B.; Lehner, P.J.; Morrell, N.W. Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II. J. Biol. Chem. 2010, 285, 37641-37649.
35. Boname, J.M.; Thomas, M.; Stagg, H.R.; Xu, P.; Peng, J.; Lehner, P.J. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 2010, 11, 210-220.
36. Cadwell, K.; Coscoy, L. The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets. J. Virol. 2008, 82, 4184-4189.
37. Cadwell, K.; Coscoy, L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005, 309, 127-130.
38. Wang, X.; Herr, R.A.; Chua, W.J.; Lybarger, L.; Wiertz, E.J.; Hansen, T.H. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 2007, 177, 613-624.
39. Vosper, J.M.; McDowell, G.S.; Hindley, C.J.; Fiore-Heriche, C.S.; Kucerova, R.; Horan, I.; Philpott, A. Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis. J. Biol. Chem. 2009, 284, 15458-15468.
40. Ishikura, S.; Weissman, A.M.; Bonifacino, J.S. Serine residues in the cytosolic tail of the T-cell antigen receptor alpha-chain mediate ubiquitination and endoplasmic reticulum-associated degradation of the unassembled protein. J. Biol. Chem. 2010, 285, 23916-23924.
41. Galan, J.M.; Haguenauer-Tsapis, R. Ubiquitin lys63 is involved in ubiquitination of a yeast plasma membrane protein. EMBO J. 1997, 16, 5847-5854.
42. Haglund, K.; Di Fiore, P.P.; Dikic, I. Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem. Sci. 2003, 28, 598-603.
43. Haglund, K.; Sigismund, S.; Polo, S.; Szymkiewicz, I.; Di Fiore, P.P.; Dikic, I. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat. Cell Biol. 2003, 5, 461-466.
44. Traub, L.M.; Lukacs, G.L. Decoding ubiquitin sorting signals for clathrin-dependent endocytosis by CLASPs. J. Cell Sci. 2007, 120, 543-553.
45. Barriere, H.; Nemes, C.; Lechardeur, D.; Khan-Mohammad, M.; Fruh, K.; Lukacs, G.L. Molecular basis of oligoubiquitin-dependent internalization of membrane proteins in Mammalian cells. Traffic 2006, 7, 282-297.
46. Duncan, L.M.; Piper, S.; Dodd, R.B.; Saville, M.K.; Sanderson, C.M.; Luzio, J.P.; Lehner, P.J. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 2006, 25, 1635-1645.
47. Huang, F.; Kirkpatrick, D.; Jiang, X.; Gygi, S.; Sorkin, A. Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Mol. Cell 2006, 21, 737-748.
48. Geetha, T.; Jiang, J.; Wooten, M.W. Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling. Mol. Cell 2005, 20, 301-312.
49. Hicke, L.; Schubert, H.L.; Hill, C.P. Ubiquitin-binding domains. Nat. Rev. Mol. Cell Biol. 2005, 6, 610-621.
50. Varadan, R.; Assfalg, M.; Haririnia, A.; Raasi, S.; Pickart, C.; Fushman, D. Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J. Biol. Chem. 2004, 279, 7055-7063.
51. Pickart, C.M.; Fushman, D. Polyubiquitin chains: Polymeric protein signals. Curr. Opin. Chem. Biol. 2004, 8, 610-616.
52. Ye, Y.; Rape, M. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 2009, 10, 755-764.
53. Duncan, L.M.; Nathan, J.A.; Lehner, P.J. Stabilization of an E3 ligase-E2-ubiquitin complex increases cell surface MHC class I expression. J. Immunol. 2010, 184, 6978-6985.
54. Kirkpatrick, D.S.; Hathaway, N.A.; Hanna, J.; Elsasser, S.; Rush, J.; Finley, D.; King, R.W.; Gygi, S.P. Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology. Nat. Cell Biol. 2006, 8, 700-710.
55. Goto, E.; Yamanaka, Y.; Ishikawa, A.; Aoki-Kawasumi, M.; Mito-Yoshida, M.; Ohmura-Hoshino, M.; Matsuki, Y.; Kajikawa, M.; Hirano, H.; Ishido, S. Contribution of Lysine 11-linked Ubiquitination to MIR2-mediated Major Histocompatibility Complex Class I Internalization. J. Biol. Chem. 2010, 285, 35311-35319.
56. Bowers, K.; Piper, S.C.; Edeling, M.A.; Gray, S.R.; Owen, D.J.; Lehner, P.J.; Luzio, J.P. Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII. J. Biol. Chem. 2006, 281, 5094-5105.
57. Collin, N.; Guerin, J.L.; Drexler, I.; Blanie, S.; Gelfi, J.; Boullier, S.; Foucras, G.; Sutter, G.; Messud-Petit, F. The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Virology 2005, 343, 171-178.
58. De Gassart, A.; Camosseto, V.; Thibodeau, J.; Ceppi, M.; Catalan, N.; Pierre, P.; Gatti, E. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 3491-3496.
59. Ishido, S.; Matsuki, Y.; Goto, E.; Kajikawa, M.; Ohmura-Hoshino, M. MARCH-I: A new regulator of dendritic cell function. Mol. Cells 2010, 29, 229-232.
60. Walseng, E.; Furuta, K.; Bosch, B.; Weih, K.A.; Matsuki, Y.; Bakke, O.; Ishido, S.; Roche, P.A. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 170, 20465-20470.
61. Hoer, S.; Smith, L.; Lehner, P.J. MARCH-IX mediates ubiquitination and downregulation of ICAM-1. FEBS Lett. 2007, 581, 45-51.
62. Hor, S.; Ziv, T.; Admon, A.; Lehner, P.J. Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol. Cell. Proteomics 2009, 8, 1959-1971.
63. Nice, T.J.; Deng, W.; Coscoy, L.; Raulet, D.H. Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase. J. Immunol. 2010, 185, 5369-5376.
64. Wang, X.; Herr, R.A.; Rabelink, M.; Hoeben, R.C.; Wiertz, E.J.; Hansen, T.H. Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation substrates. J. Cell Biol. 2009, 187, 655-668.
65. Nakamura, N.; Fukuda, H.; Kato, A.; Hirose, S. MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking. Mol. Biol. Cell 2005, 16, 1696-1710.
66. Fukuda, H.; Nakamura, N.; Hirose, S. MARCH-III Is a novel component of endosomes with properties similar to those of MARCH-II. J. Biochem. 2006, 139, 137-145.
67. Nakamura, N.; Kimura, Y.; Tokuda, M.; Honda, S.; Hirose, S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 2006, 7, 1019-1022.
68. Hassink, G.; Kikkert, M.; van Voorden, S.; Lee, S.J.; Spaapen, R.; van Laar, T.; Coleman, C.S.; Bartee, E.; Fruh, K.; Chau, V.; Wiertz, E. TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem. J. 2005, 388, 647-655.
69. Nathan, J.A.; Sengupta, S.; Wood, S.A.; Admon, A.; Markson, G.; Sanderson, C.; Lehner, P.J. The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X. Traffic 2008, 9, 1130-1145.
70. Morokuma, Y.; Nakamura, N.; Kato, A.; Notoya, M.; Yamamoto, Y.; Sakai, Y.; Fukuda, H.; Yamashina, S.; Hirata, Y.; Hirose, S. MARCH-XI, a novel transmembrane ubiquitin ligase implicated in ubiquitin-dependent protein sorting in developing spermatids. J. Biol. Chem. 2007, 282, 24806-24815.